TXN and primary biliary cholangitis: Additionally, treatment with ursodeoxycholic acid (UDCA) enhanced hepatic expression of Nrf2 and increased the protein abundance of the Nrf2 targets Trx and Trxr-1 in patients with primary biliary cirrhosis [60].